Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain

Starting soon · Not applicable

Conditions studied: Neuropathic Pain, Chronic Pain

In brief

This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.

Key facts

Study ID

NCT07264920

Run by

Johns Hopkins University

People needed

70

Starts

2026-10-01

Expected to finish

2030-01-01

Last updated by the study team

2026-08-10

Who can join

Age: 5 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to verbalize pain scores
• Oncology patients with acute and/or chronic pain

You may not qualify if…

• Patients with Implantable Devices
• Epilepsy
• Pregnancy
• A history of myocardial infarction or ischemic heart disease within the past six months
• History of severe heart arrhythmia or equivalent heart disease
• Open Wounds or Infections at site of electrode placement
• A history of intolerance to transcutaneous electronic nerve stimulation

Where it is running

• Johns Hopkins Children's Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.